This threat assessment addresses the implications of the ongoing Marburg virus disease (MVD) outbreak in Rwanda for the European Union/European Economic Area (EU/EEA).
ECDC is helping countries in the Western Balkans and Türkiye improve their infectious disease prevention and control systems and public health workforce. This will prepare the countries for their future participation in ECDC work.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 28 September - 4 October 2024 and includes updates on Marburg virus disease, Mpox, avian influenza A(H5N1) human cases, an overview of respiratory virus epidemiology in the EU/EEA, West Nile virus, dengue, SARS-CoV-2, MERS-CoV, and chikungunya.
This ECDC survey protocol describes the technical requirements for implementing a genomic surveillance-based survey of CRAb isolates from patients seeking hospital care. It is intended for first use in 2024–2025.
This technical report is a laboratory manual that accompanies the ‘Survey protocol for the ECDC genomic-based surveillance of carbapenem-resistant Acinetobacter baumannii in Europe’.
This systematic review aims to provide the evidence regarding the demographic, environmental, and epidemiological or other characteristics associated with carrying T. cruzi infection in at-risk individuals residing in areas non-endemic for CD.
This report aims to assess the available evidence on the risk of tick-borne encephalitis virus (TBEV) transmission through substances of human origin (SoHO) such as blood, organs, tissues, and cells, and proposes potential safety measures.
